Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Luca Lo Nigro, Giulio Pulvirenti, Emanuela Cannata, Paola Bonaccorso, Nellina Andriano & Giovanna Russo. (2019) “Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line”. Pediatric Hematology and Oncology 36:7, pages 438-444.
Read now
Read now
Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, Philippe Rousselot, Norbert Vey, Arnaud Pigneux, Norbert Ifrah & Hervé Dombret. (2015) Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup. Leukemia & Lymphoma 56:4, pages 847-857.
Read now
Read now
Articles from other publishers (32)
Zeynep Tuğba GÜVEN, Şaziye Esra TUBAY, Serhat ÇELİK, Muzaffer KEKLİK & Ali ÜNAL. (2023) Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experienceRelaps/refrakter T hücreli akut lenfoblastik lösemili erişkin hastalarda klofarabin, siklofosfamid, etoposid (CLOVE): tek merkez deneyimi. Cukurova Medical Journal 48:2, pages 535-540.
Crossref
Crossref
Surya K. De. 2022. Fundamentals of Cancer Detection, Treatment, and Prevention. Fundamentals of Cancer Detection, Treatment, and Prevention
67
131
.
Koji Nakajima, Hirohito Kubota, Itaru Kato, Kiyotaka Isobe, Hiroo Ueno, Kagehiro Kozuki, Kuniaki Tanaka, Naoko Kawabata, Takashi Mikami, Kosuke Tamefusa, Ritsuo Nishiuchi, Satoshi Saida, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi & Junko Takita. (2022)
PAX5
alterations in an infant case of
KMT2A
‐rearranged leukemia with lineage switch
. Cancer Science 113:7, pages 2472-2476.
Crossref
Crossref
Kavitha Ramaswamy, Peter G. SteinherzAnurag K. Agrawal, Christopher J. ForlenzaAudrey Mauguen, Mikhail Roshal, Tanya TrippettNancy A. KernanMaria Luisa SulisNeerav Shukla. (2022) Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML. Blood Advances 6:8, pages 2688-2694.
Crossref
Crossref
Anita W. RijneveldBronno van der HoltOkke de WeerdtBart J. Biemond, Arjen A. van de LoosdrechtLotte E. van der WagenMar Bellido, Michel van GelderWalter J. F. M. van der Velden, Dominik SelleslagDaniëlle van Lammeren-VenemaConstantijn J. M. Halkes, Rob FijnheerViolaine HavelangeGeerte L. van SluisMarie-Cecile LegdeurDries DeerenAlain GadisseurHarm A. M. SinnigeDimitri A. BreemsAurélie JaspersOllivier LegrandWim E. TerpstraRinske S. BoersmaDominiek MazureAgnes TriffetLidwine W. TickKarolien BeelJohan A. MaertensH. Berna BeverlooMarleen Bakkus, Christa H. E. HomburgValerie de Haas, Vincent H. J. van der Velden & Jan J. Cornelissen. (2022) Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial. Blood Advances 6:4, pages 1115-1125.
Crossref
Crossref
John C. Molina & Nirali N. Shah. 2022. Clinical Management of Acute Lymphoblastic Leukemia. Clinical Management of Acute Lymphoblastic Leukemia
295
328
.
Patrick A. BrownBijal ShahAnjali AdvaniPatricia AounMichael W. BoyerPatrick W. BurkeDaniel J. DeAngeloShira DinnerAmir T. FathiJordan GauthierNitin JainSuzanne KirbyMichaela LiedtkeMark LitzowAaron LoganSelina LugerLori J. ManessStephanie MassaroRyan J. MattisonWilliam MayOlalekan OluwoleJae ParkAmanda PrzespolewskiSravanti RangarajuJeffrey E. RubnitzGeoffrey L. UyMadhuri VusirikalaMatthew Wieduwilt, Beth LynnRyan A. BerardiDeborah A. Freedman-CassMallory Campbell. (2021) Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 19:9, pages 1079-1109.
Crossref
Crossref
Maziar Moradi-Lakeh, Mohsen Yaghoubi, Patrick Seitz, Mehdi Javanbakht & Elisabeth Brock. (2021) Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland. Advances in Therapy 38:6, pages 3427-3443.
Crossref
Crossref
Ryo Akazawa, Itaru Kato, Hirohito Kubota, Kiyotaka Isobe, Hiroaki Masuno, Masamitsu Mikami, Mitsutaka Shiota, Kagehiro Kouzuki, Naoko Kawabata, Kuniaki Tanaka, Satoshi Saida, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi & Junko Takita. (2021) Inotuzumabozogamicin is an effective treatment for CD22‐positive acute undifferentiated leukemia: A case report. Pediatric Blood & Cancer 68:5.
Crossref
Crossref
Shiho Wakase, Takanori Teshima, Jie Zhang, Qiufei Ma, Yoko Watanabe, Hongbo Yang, Cynthia Z. Qi, Xinglei Chai, Yanwen Xie, Eric Q. Wu & Ataru Igarashi. (2021) Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan. Transplantation and Cellular Therapy 27:3, pages 241.e1-241.e11.
Crossref
Crossref
Sachio Fujita, Ryosuke Matsuno, Naoko Kawabata, Yumiko Sugishita, Ryota Kaneko, Masaya Koganesawa, Kosuke Akiyama, Daisuke Toyama & Shohei Yamamoto. (2021) Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report. SAGE Open Medical Case Reports 9, pages 2050313X2110155.
Crossref
Crossref
Qiufei Ma, Jie Zhang, Elliott O'Brien, Amber L Martin & Andrea Chassot Agostinho. (2020) Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia. Journal of Comparative Effectiveness Research 9:12, pages 849-860.
Crossref
Crossref
Hyery Kim. (2020) Treatments for children and adolescents with AML. BLOOD RESEARCH 55:S1, pages S5-S13.
Crossref
Crossref
F. A. Makhacheva & T. T. Valiev. (2020) Pediatric acute myeloid leukemias treatment: current scientific view. Oncohematology 15:1, pages 10-27.
Crossref
Crossref
Jinhan Xie, Miriam Span, Erik Maarseveen, Jurgen Langenhorst, Alan V. Boddy, Keith C.S. Sia, Rosemary Sutton, Nicola Venn, Arjen M. Punt, Vanessa Tyrrell, Michelle Haber, Toby Trahair, Loretta Lau, Glenn M. Marshall & Richard B. Lock. (2019) Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer 67:4.
Crossref
Crossref
Magdi Elsallab, Bruce L Levine, Alan S Wayne & Mohamed Abou-El-Enein. (2020) CAR T-cell product performance in haematological malignancies before and after marketing authorisation. The Lancet Oncology 21:2, pages e104-e116.
Crossref
Crossref
Patrick BrownHiroto InabaColleen AnnesleyJill BeckSusan ColaceMari DallasKenneth DeSantesKara KellyCarrie KitkoNorman LacayoNicole LarrierLuke MaeseKris MahadeoRonica NandaValentina NardiVilmarie RodriguezJenna RossoffLaura SchuettpelzLewis SilvermanJessica SunWeili SunDavid TeacheyVictor WongGregory Yanik, Alyse Johnson-ChillaNdiya Ogba. (2020) Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:1, pages 81-112.
Crossref
Crossref
Omima Mustafa, Khalid Abdalla, Aeshah A AlAzmi, Naglla Elimam, Mohammed Burhan Abrar & Wasil Jastaniah. (2018) FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies. Journal of Oncology Pharmacy Practice 25:8, pages 1831-1838.
Crossref
Crossref
Reith R Sarkar, Nicholas J Gloude, Deborah Schiff & James D Murphy. (2019) Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. JNCI: Journal of the National Cancer Institute 111:7, pages 719-726.
Crossref
Crossref
John K. LinBenjamin J. LermanJames I. BarnesBrian C. BoursiquotYuan Jin TanAlex Q.L. RobinsonKara L. DavisDouglas K. OwensJeremy D. Goldhaber-Fiebert. (2018) Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 36:32, pages 3192-3202.
Crossref
Crossref
James McCloskey, Jamie Koprivnikar, Stefan Faderl, Dirk Reinhardt & Nobuko Hijiya. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
287
309
.
Guang-yao Li, Li Zhang, Ji-zhu Liu, Shou-guo Chen, Tai-wu Xiao, Guo-zhen Liu, Jing-xia Wang, Le-xin Wang & Ming Hou. (2016) Marine drug Haishengsu increases chemosensitivity to conventional chemotherapy and improves quality of life in patients with acute leukemia. Biomedicine & Pharmacotherapy 81, pages 160-165.
Crossref
Crossref
Anar Tagiyev, Huseyin Demirbilek, Betul Tavil, Gonul Buyukyilmaz, Fatma Gumruk & Mualla Cetin. (2016) Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse. Journal of Pediatric Hematology/Oncology 38:3, pages 232-234.
Crossref
Crossref
Anthony P. Y. Liu, Vincent Lee, C. K. Li, S. Y. Ha & Alan K. S. Chiang. (2015) Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide. Annals of Hematology 95:3, pages 501-507.
Crossref
Crossref
Brigitte Nelken, Helene Cave, Guy Leverger, Claire Galambrun, Genevieve Plat, Claudine Schmitt, Caroline Thomas, C?cile V?rit?, Benoit Brethon, Virginie Gandemer, Yves Bertrand, Andr? Baruchel & Pierre Rohrlich. (2016) A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Pediatric Blood & Cancer 63:2, pages 270-275.
Crossref
Crossref
Iolanda D?Alimonte, Eleonora Nargi, Mariachiara Zuccarini, Paola Lanuti, Patrizia Di Iorio, Patricia Giuliani, Lucia Ricci-Vitiani, Roberto Pallini, Francesco Caciagli & Renata Ciccarelli. (2015) Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells. Purinergic Signalling 11:3, pages 331-346.
Crossref
Crossref
Hideki Nakayama, Ken Tabuchi, Akio Tawa, Ichiro Tsukimoto, Masahiro Tsuchida, Akira Morimoto, Hiromasa Yabe, Keizo Horibe, Ryoji Hanada, Masue Imaizumi, Yasuhide Hayashi, Kazuko Hamamoto, Ryoji Kobayashi, Kazuko Kudo, Akira Shimada, Takako Miyamura, Hiroshi Moritake, Daisuke Tomizawa, Takashi Taga & Souichi Adachi. (2014) Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol. International Journal of Hematology 100:2, pages 171-179.
Crossref
Crossref
Jennifer Davila, Emily Slotkin & Thomas Renaud. (2013) Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments. Pediatric Drugs 16:2, pages 151-168.
Crossref
Crossref
Neerav Shukla, Rachel Kobos, Thomas Renaud, Laurel J. Steinherz & Peter G. Steinherz. (2014) Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia. Pediatric Blood & Cancer 61:3, pages 431-435.
Crossref
Crossref
Miguel Bonilla & Raul C. Ribeiro. 2014. Pediatric Hematology-Oncology in Countries with Limited Resources. Pediatric Hematology-Oncology in Countries with Limited Resources
239
255
.
Pawel Robak & Tadeusz Robak. (2013) Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treatment Reviews 39:8, pages 851-861.
Crossref
Crossref
Øystein Bruserud, Håkon Reikvam, Astrid Olsnes Kittang, Aymen Bushra Ahmed, Tor Henrik Anderson Tvedt, Malvin Sjo & Kimberley Joanne Hatfield. (2012) High-dose etoposide in allogeneic stem cell transplantation. Cancer Chemotherapy and Pharmacology 70:6, pages 765-782.
Crossref
Crossref